Skip to main content
Clinical Trials/NCT02517411
NCT02517411
Completed
N/A

Effects of a Physiotherapy Program in Patients With Stable Chronic Obstructive Pulmonary Disease

Universidad de Granada1 site in 1 country40 target enrollmentSeptember 2015
ConditionsCOPD

Overview

Phase
N/A
Intervention
Not specified
Conditions
COPD
Sponsor
Universidad de Granada
Enrollment
40
Locations
1
Primary Endpoint
Changes in Muscle strength
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is a lung disease that is characterized by incompletely reversible airflow obstruction. It is projected to be the fifth leading burden of disease worldwide by the year 2020. Pulmonary dysfunction reduces exercise capacity in COPD patients, and it has been previously shown that COPD patients suffer deterioration in their quality of life. The objective of this study is to examine the effects of a physical therapy intervention in stable patients with COPD.

Detailed Description

Chronic obstructive pulmonary disease (COPD) is one of the leading diseases causing mortality and morbidity, despite advanced pharmacotherapy and therapeutic management. Although COPD primarily affects the lungs, it also implies extrapulmonary manifestations, such as nutritional depletion, skeletal muscle dysfunction, and abnormal respiratory muscles. Pulmonary rehabilitation is widely used to treat COPD patients and it has been shown that pulmonary rehabilitation should be implemented at all COPD stages, bringing them benefits in terms of improved exercise capacity, symptoms, and quality of life.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
June 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marie Carmen Valenza

PhD

Universidad de Granada

Eligibility Criteria

Inclusion Criteria

  • COPD diagnosis
  • No contraindication of physiotherapy.
  • Signed written consent.
  • Medical approval for inclusion.

Exclusion Criteria

  • Acute exacerbation in the previous month
  • Contraindications of physiotherapy.
  • Neurological, orthopedic or heart disease.

Outcomes

Primary Outcomes

Changes in Muscle strength

Time Frame: Baseline, 8 weeks

Quadriceps strength will be assessed with a portable dynamometer.

Changes in Exercise capacity

Time Frame: Baseline, 8 weeks

Five times sit to stand test (5STS) will be used to assess exercise capacity, 5STS is a simple assessment tool that is feasible in all healthcare settings, and may be a rapid method of assessing changes in exercise capacity in COPD and screening for poor physical functioning individuals.

Secondary Outcomes

  • Changes in Quality of life(Baseline, 8 weeks)
  • Changes in Respiratory function(Baseline, 8 weeks)
  • Changes in Dyspnea perception(Baseline, 8 weeks)
  • Changes in Fatigue(Baseline, 8 weeks)
  • Impact of COPD(Baseline, 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials